278 related articles for article (PubMed ID: 36900005)
21. The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma.
Nieder C; Petersen S; Petersen C; Thames HD
Ann Hematol; 2001 Jan; 80(1):2-8. PubMed ID: 11233771
[TBL] [Abstract][Full Text] [Related]
22. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
23. Non-Hodgkin's lymphoma: A review.
Singh R; Shaik S; Negi BS; Rajguru JP; Patil PB; Parihar AS; Sharma U
J Family Med Prim Care; 2020 Apr; 9(4):1834-1840. PubMed ID: 32670927
[TBL] [Abstract][Full Text] [Related]
24. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas.
Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ
Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
Liendo C; Danieu L; Al-Katib A; Koziner B
Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
[TBL] [Abstract][Full Text] [Related]
26. Non-Hodgkin's lymphoma after prolonged remission of Hodgkin's disease in an HIV-infected patient.
Montalban C; Bellas C; Rodriguez-Garcia JL; Aguado M; Fernandez-Muñoz R
Ann Oncol; 1991 Sep; 2(8):585-7. PubMed ID: 1665342
[TBL] [Abstract][Full Text] [Related]
27. Smoking and lymphoma risk in the European prospective investigation into cancer and nutrition.
Nieters A; Rohrmann S; Becker N; Linseisen J; Ruediger T; Overvad K; Tjønneland A; Olsen A; Allen NE; Travis RC; Bingham S; Khaw KT; Ardanaz E; Redondo ML; Basterrechea M; Martinez C; Tormo MJ; Rosso S; Tagliabue G; Masala G; Mattiello A; Tumino R; Boeing H; Bergmann M; Kaaks R; Trichopoulou A; Trichopoulos D; Peeters PH; Bueno-de-Mesquita B; Boffetta P; Brennan P; Ferrari P; Neasham D; Lund E; Berglund G; Manjer J; Hallmans G; Johansson I; Vineis P; Riboli E
Am J Epidemiol; 2008 May; 167(9):1081-9. PubMed ID: 18321867
[TBL] [Abstract][Full Text] [Related]
28. Histopathology of Hodgkin's lymphoma.
Eberle FC; Mani H; Jaffe ES
Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
[TBL] [Abstract][Full Text] [Related]
29. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
[TBL] [Abstract][Full Text] [Related]
30. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
31. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
32. Concomitant sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease) and diffuse large B-cell lymphoma: a case report.
Moore JC; Zhao X; Nelson EL
J Med Case Rep; 2008 Mar; 2():70. PubMed ID: 18321383
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
Asano N; Kinoshita T; Tamaru J; Ohshima K; Yoshino T; Niitsu N; Tsukamoto N; Hirabayashi K; Izutsu K; Taniwaki M; Morishima Y; Nakamura S
Haematologica; 2011 Nov; 96(11):1636-43. PubMed ID: 21859738
[TBL] [Abstract][Full Text] [Related]
34. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
35. Hodgkin's and non-Hodgkin's lymphomas.
Rademaker J
Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
[TBL] [Abstract][Full Text] [Related]
36. Biologic aspects of AIDS-associated non-Hodgkin's lymphoma.
Knowles DM
Curr Opin Oncol; 1993 Sep; 5(5):845-51. PubMed ID: 8218497
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin's lymphoma: evolving concepts with implications for practice.
Meyer RM; Ambinder RF; Stroobants S
Hematology Am Soc Hematol Educ Program; 2004; ():184-202. PubMed ID: 15561683
[TBL] [Abstract][Full Text] [Related]
38. Multiinstitution study of non-Hodgkin's lymphomas using frozen section immunoperoxidase: the Southeastern Cancer Study Group experience.
Borowitz MJ; Newby S; Brynes RK; Cousar JB; Whitcomb CC; Crissman JD; Byrne GE; Collins RD
Blood; 1984 May; 63(5):1147-52. PubMed ID: 6370333
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of composite nodal B-cell lymphoma and subsequent Hodgkin's disease by flow cytometry and immunohistochemistry. Case report and review of the literature.
Dunphy CH; Craver JL; Emerson WA
Arch Pathol Lab Med; 1997 Jun; 121(6):637-40. PubMed ID: 9199634
[TBL] [Abstract][Full Text] [Related]
40. HCV and HGV in B-cell non-Hodgkin's lymphoma.
Ellenrieder V; Weidenbach H; Frickhofen N; Michel D; Prümmer O; Klatt S; Bernas O; Mertens T; Adler G; Beckh K
J Hepatol; 1998 Jan; 28(1):34-9. PubMed ID: 9537861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
